CLINICAL_TRIALS
trial_result
· 2015-05-06
Clinical Trial Update: Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial comparing human albumin with cabergoline to prevent ovarian hyperstimulation syndrome in assisted reproductive technology programs has …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Royan Institute | Conditions: Ovarian Hyperstimulation Syndrome | Phase 1, Phase 2 | Status: COMPLETED